LYOPHILISED POWDER OF VORTIOXETINE PAMOATE FOR INJECTIONS AND METHOD FOR ITS PREPARATION Russian patent published in 2025 - IPC A61K9/19 A61K31/495 A61P25/24 

Abstract RU 2837640 C2

FIELD: chemistry.

SUBSTANCE: group of inventions relates to vortioxetine pamoate powder for injections. Vortioxetine pamoate powder for injections consists of vortioxetine pamoate and pharmaceutically acceptable excipients; where pharmaceutically acceptable excipients include a suspending agent, where the suspending agent is sodium carboxymethyl cellulose, where the suspending agent is from 2.3 to 13.8 wt.%, preferably from 6.9 to 10.8 wt.%, of the total weight of the powder for injections, where pharmaceutically acceptable excipients additionally include mannitol as a lyoprotector and an osmotic pressure regulator, where mannitol is from 20.7 to 32.5 wt.% of the total weight of the powder for injections; and wherein the weight fraction of vortioxetine pamoate ranges from 54.0% to 72.4% in terms of the total weight of the powder for injections. Also disclosed is a method of producing vortioxetine pamoate powder for injections.

EFFECT: group of inventions provides stability of the composition with respect to particle sedimentation and delamination.

8 cl, 2 dwg, 5 ex

Similar patents RU2837640C2

Title Year Author Number
LIQUID COMPOSITIONS CONTAINING TASIMELTEON AND METHODS OF THEIR USE 2020
  • Phadke Deepak
  • Polymeropoulos Mihael
RU2806302C1
STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE 2014
  • Dkhuppad Ulkhas
  • Katkurvar Ashok
  • Gupta Yashvant
  • Ankam Radzhesh
  • Dkhatrak Chandrakant
RU2687551C2
SUSPENSION COMPOSITIONS OF CYCLOSPORINE A FOR SUBCONJUNCTIVAL AND PERIOCULAR INJECTION 2015
  • Gor Anuradkha V.
  • Khou Khao
  • Pudzhara Chetan P.
  • Nirvannan Sesha
  • Vu Ke
RU2713953C2
PHARMACEUTICAL COMPOSITIONS FOR INJECTIONS AND USE THEREOF 2020
  • Valle Colon, Brenda, L
  • Freehauf, Keith
  • Guerino, Frank
  • Kulczar, Christopher, D
  • Carrillo, Brian
RU2829447C2
COMPOSITION WITH DELAYED RELEASE, INCLUDING OCTREOTIDE AND TWO OR MORE POLYLACTIDE AND GLYCOLIDE COPOLYMERS 2006
  • Petersen Khol'Ger
  • Al'Khajm Markus
RU2464972C2
INJECTABLE COMPOSITIONS OF PROLONGED ACTION OF SALTS OF KETAMINE PAMOATE 2020
  • Lin, Ton-Kho
  • Ven, Yun-Shun
  • Chen, Chia-Syan
  • Lyu, In-Tin
  • Khou, Zhuj-Chzhi
  • U, Chzhi-Zhun
RU2825874C1
OCTREOTIDE-CONTAINING COMPOSITION WITH DELAYED RELEASE WITH STABLY HIGH LEVEL OF IMPACT 2009
  • Markus Al'Khajm
  • Khol'Ger Peterzen
RU2526822C2
METHOD FOR PREPARING SOLID, ORAL PHARMACEUTICAL FORMULATION 2009
  • Benke Klaus
RU2493850C2
METHOD FOR MAKING SOLID ORAL PHARMACEUTICAL COMPOSITION 2004
  • Benke Klaus
RU2379036C2
PROLONGED RELEASE FORMULATION CONTAINING OCTREOTIDE AND THREE LINEAR POLYMERS OF POLY(LACTIDE-CO-GLYCOLIC ACID) 2009
  • Khol'Ger Peterzen
  • Markus Al'Khajm
RU2541104C2

RU 2 837 640 C2

Authors

Lyu, Tenfej

Fan, Tszyalej

Van, Yanan

Ni, Laji

Dates

2025-04-02Published

2021-08-05Filed